Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23431
Gene Symbol: AP4E1
AP4E1
0.110 Biomarker phenotype HPO
Entrez Id: 1107
Gene Symbol: CHD3
CHD3
0.100 Biomarker phenotype HPO
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.100 Biomarker phenotype HPO
Entrez Id: 57410
Gene Symbol: SCYL1
SCYL1
0.100 Biomarker phenotype HPO
Entrez Id: 84572
Gene Symbol: GNPTG
GNPTG
0.020 GeneticVariation phenotype BEFREE 14 variations were found in the three genes 3 of which, including a novel variant within intronic region of GNPTG and a heterozygous 2-bp deletion in coding region of GNPTAB, co-segregated with stuttering in the families they were found. 29289611 2018
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE 14 variations were found in the three genes 3 of which, including a novel variant within intronic region of GNPTG and a heterozygous 2-bp deletion in coding region of GNPTAB, co-segregated with stuttering in the families they were found. 29289611 2018
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.320 Biomarker phenotype CTD_human CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering. 21108403 2010
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.320 Biomarker phenotype BEFREE CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering. 21108403 2010
Entrez Id: 2004
Gene Symbol: ELK3
ELK3
0.010 Biomarker phenotype BEFREE Abnormal processing of prosodic boundary in adults who stutter: An ERP study. 30423511 2018
Entrez Id: 84650
Gene Symbol: EBPL
EBPL
0.010 Biomarker phenotype BEFREE Abnormal processing of prosodic boundary in adults who stutter: An ERP study. 30423511 2018
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.030 GeneticVariation phenotype BEFREE After completing this paper, readers should be able to (a) identify key epidemiological findings for the three speech phenotypes that were discussed (DAS, speech delay, and stuttering); (b) summarize the findings of the behavioral genetic studies of speech disorders that were presented; (c) identify four specific challenges that may impede future molecular genetic studies of these phenotypes; (d) describe the methodological sequence that led to the discovery of the FOXP2 gene; and (e) summarize the two research strategies that were presented to potentially reduce sample heterogeneity for future molecular genetics research. 12160352 2003
Entrez Id: 4036
Gene Symbol: LRP2
LRP2
0.010 Biomarker phenotype BEFREE Although pallidal deep brain stimulation (GPi-DBS) is an effective treatment for dystonia, it may cause important stimulation-induced side-effects such as hypokinetic dysarthria or stuttering. 29576500 2019
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.010 Biomarker phenotype BEFREE Although pallidal deep brain stimulation (GPi-DBS) is an effective treatment for dystonia, it may cause important stimulation-induced side-effects such as hypokinetic dysarthria or stuttering. 29576500 2019
Entrez Id: 9159
Gene Symbol: PCSK7
PCSK7
0.010 Biomarker phenotype BEFREE Although the LPC elicited in CWS-eRecovered and CWNS did not differ, the LPC elicited in the CWS-ePersisted was smaller in amplitude compared with that in CWNS. 29098269 2017
Entrez Id: 4744
Gene Symbol: NEFH
NEFH
0.010 Biomarker phenotype BEFREE An enrichment analysis demonstrated that the genes identified with the stuttering cortical network shared a significantly overrepresented biological functionality of Neurofilament Cytoskeleton Organization (NEFH, NEFL and INA). 31669185 2020
Entrez Id: 9118
Gene Symbol: INA
INA
0.010 Biomarker phenotype BEFREE An enrichment analysis demonstrated that the genes identified with the stuttering cortical network shared a significantly overrepresented biological functionality of Neurofilament Cytoskeleton Organization (NEFH, NEFL and INA). 31669185 2020
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.010 Biomarker phenotype BEFREE Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. 19590515 2009
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.030 Biomarker phenotype BEFREE Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. 19590515 2009
Entrez Id: 1738
Gene Symbol: DLD
DLD
0.010 Biomarker phenotype BEFREE At the outset of this article, we posed the question of whether or not the current evidence from genetic studies of DLD and stuttering indicate that it would be fruitful to conduct studies aimed at determining the gene location for each of these disorders. 1408200 1992
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.030 Biomarker phenotype BEFREE CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering. 21108403 2010
Entrez Id: 25859
Gene Symbol: PART1
PART1
0.010 Biomarker phenotype BEFREE Development of an internet version of the Lidcombe Program of early stuttering intervention: A trial of Part 1. 27908200 2018
Entrez Id: 6006
Gene Symbol: RHCE
RHCE
0.010 GeneticVariation phenotype BEFREE Evidence is presented that RHD, RHCE, and other RH genes, may be interesting candidates to consider when searching for the genetic basis of hair whorl rotation (i.e., clockwise or counterclockwise), handedness (i.e., right handed, left handed or ambidextrous), speech laterality (i.e., right brained or left brained), speech dyslexia (e.g., stuttering), sexual orientation (i.e., heterosexual, homosexual, bisexual, or transsexual), schizophrenia, bipolar disorder, and autism spectrum disorder. 16337093 2006
Entrez Id: 5730
Gene Symbol: PTGDS
PTGDS
0.010 Biomarker phenotype BEFREE Findings suggest similar loci of stuttering in adults with PDS and ANS, and, for both groups, the probability of stuttering on a given word was more influenced by motor production variables than language variables. 30593859 2019
Entrez Id: 5172
Gene Symbol: SLC26A4
SLC26A4
0.010 Biomarker phenotype BEFREE Findings suggest similar loci of stuttering in adults with PDS and ANS, and, for both groups, the probability of stuttering on a given word was more influenced by motor production variables than language variables. 30593859 2019
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.010 Biomarker phenotype BEFREE Following treatment with ACTH, a reduction in SWI in all the patients was accompanied by a 72% improvement in ADHD or ASD, and 83.8% improvement in stuttering. 27645286 2017